{{about|[[烟酰胺腺嘌呤二核苷酸|NAD<sup>+</sup>]]为[[受体_(生物化学)|受体]]的酶|同名但以[[烟酰胺腺嘌呤二核苷酸磷酸|NADP<sup>+</sup>]]为受体的酶|羟甲基戊二酸单酰辅酶A还原酶 (NADPH)}}
{{PBB|geneid=3156}}
{{enzyme
| Name = 羟甲基戊二酸单酰辅酶A还原酶
| Systematic_name = (''R'')-mevalonate:NAD<sup>+</sup> oxidoreductase (CoA-acylating)
| Acronym = HMGCR
| Other_names = β-hydroxy-β-methylglutaryl coenzyme A reductase; β-hydroxy-β-methylglutaryl CoA-reductase; 3-hydroxy-3-methylglutaryl coenzyme A reductase; hydroxymethylglutaryl coenzyme A reductase
| EC_number = 1.1.1.88
| CAS_number = 37250-24-1 
| IUBMB_EC_number = 1/1/1/88 
| GO_code = 0042282 
| image = 
| width = 
| caption = 
}}
'''羟甲基戊二酸单酰辅酶A还原酶'''（{{lang-en|hydroxymethylglutaryl-CoA reductase}}，[[EC编号|EC]] [http://enzyme.expasy.org/EC/1.1.1.88 1.1.1.88]）简称“'''HMG-CoA还原酶'''”，是一种以[[烟酰胺腺嘌呤二核苷酸|NAD<sup>+</sup>]]或[[烟酰胺腺嘌呤二核苷酸磷酸|NADP<sup>+</sup>]]为[[受体_(生物化学)|受体]]、作用于[[供体|供体]][[次甲基|CH]]-[[羟基|OH]][[基团|基团]]上的[[氧化还原酶|氧化还原酶]]。这种[[酶|酶]]能[[催化|催化]]以下[[酶促反应|酶促反应]]：

:(''R'')-[[甲羟戊酸|甲羟戊酸]] + [[辅酶A|辅酶A]] + 2 [[烟酰胺腺嘌呤二核苷酸|NAD<sup>+</sup>]] <math>\rightleftharpoons</math> [[3-羟基-3-甲基戊二酸单酰辅酶A|3-羟基-3-甲基戊二酸单酰辅酶A]] + 2 NADH + 2 [[氢离子|H<sup>+</sup>]]

HMG-CoA还原酶是产生[[胆固醇|胆固醇]]等[[类异戊二烯化合物|类异戊二烯化合物]]的[[甲羟戊酸|甲羟戊酸]][[代谢途径|代谢途径]]中的[[限速酶|限速酶]]。一般来说，在[[哺乳动物|哺乳动物]][[细胞|细胞]]中HMG-CoA还原酶受到由[[低密度脂蛋白受体|低密度脂蛋白受体]]内化及[[降解|降解]][[低密度脂蛋白|低密度脂蛋白]]产生的胆固醇及胆固醇的氧化[[衍生物|衍生物]]的抑制。低密度脂蛋白是[[动脉粥样硬化|动脉粥样硬化]]的一个决定性因素，这种酶的竞争性抑制剂能诱导[[肝脏|肝脏]]低密度脂蛋白受体的[[基因表达|表达]]，使[[细胞质基质|细胞质基质]]内低密度脂蛋白的[[代谢|代谢]]增强、[[浓度|浓度]]降低。<ref name="entrez">{{cite web | title = Entrez Gene: HMGCR 3-hydroxy-3-methylglutaryl-Coenzyme A reductase| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3156| accessdate = }}</ref>因此，HMG-CoA还原酶成为被统称为“[[羟甲基戊二酸单酰辅酶A还原酶抑制剂|羟甲基戊二酸单酰辅酶A还原酶抑制剂]]”的一类被广泛使用的降胆固醇药的作用靶点。HMG-CoA被锚定在[[内质网|内质网]]膜上，且长期以来被认为拥有7个跨膜[[结构域|结构域]]，而其活性位点则位于[[蛋白质|蛋白质]][[C端|C端]]结构域中。但后来的研究表明HMG-CoA还原酶其实拥有8个跨膜结构域。<ref name="pmid1374417">{{cite journal | author = Roitelman J, Olender EH, Bar-Nun S, Dunn WA, Simoni RD | title = Immunological evidence for eight spans in the membrane domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for enzyme degradation in the endoplasmic reticulum | journal = J. Cell Biol. | volume = 117 | issue = 5 | pages = 959–73 | pmid = 1374417 | pmc = 2289486 | doi = 10.1083/jcb.117.5.959| url = |date=June 1992}}</ref>

[[人类|人类]]表达HMG-CoA还原酶的[[基因|基因]]位于[[5号染色体_(人类)|5号染色体]]长臂上（5q13.3-14）。<ref name="pmid3866240">{{cite journal | author = Lindgren V, Luskey KL, Russell DW, Francke U | title = Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 82 | issue = 24 | pages = 8567–71 | pmid = 3866240 | pmc = 390958 | doi = 10.1073/pnas.82.24.8567| url = |date=December 1985}}</ref>其他[[动物|动物]]、[[植物|植物]]和[[细菌|细菌]]也拥有具有类似作用的相关酶类。

== 反应 ==
在甲羟戊酸途径中，HMG-CoA还原酶负责将[[3-羟基-3-甲基戊二酸单酰辅酶A|3-羟基-3-甲基戊二酸单酰辅酶A]]（HMG-CoA）催化转化为[[甲羟戊酸|甲羟戊酸]]:
{|
|[[Image:MevalonatePathway_zh.png|450px]]示意图]]
|}

== 参考文献 ==
{{reflist}}
{{refbegin}}
*{{cite journal  | author=Fimognari, G.M. and Rodwell, V.W. |title=Substrate-competitive inhibition of bacterial mevalonate:nicotinamide-adenine dinucleotide oxidoreductase (acylating CoA) |journal=Biochemistry |volume=4 |pages= 2086-2090 |year= 1965}}
{{refend}}

{{EC 1.1}}

[[Category:EC_1.1.1|Category:EC 1.1.1]]
[[Category:NADH依赖性酶|Category:NADH依赖性酶]]
[[Category:已知结构的酶|Category:已知结构的酶]]